Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


逗鲨加速器不能用了-快柠檬加速器

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

逗鲨加速器不能用了-快柠檬加速器

逗鲨加速器不能用了-快柠檬加速器

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

逗鲨加速器不能用了-快柠檬加速器

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
极光 VNP 加速器  老王加速npv下载2.2.25  极狐vp加速器官网  软件分享合集地址汇总  彗星加速器加速器  梯子软件加速器  快柠檬加速器,快柠檬vp加速器,快柠檬加速器官网,